Name: Xin Weisheng
Address: 5995 Huyi Road, Shanghai, AB 123C, China
Telephone: 021 5958 5480
Price range: Competitive

17 May 2023

White House wants to improve access to opioid overdose reversal medication

President Joe Biden's administration is seeking to meet with the makers of the life-saving medication naloxone used to reverse opioid overdoses, in an effort to increase access and reduce cost
Find out more
10 May 2023

White House Assembles Secret Team to Tackle Drug Shortages, Quality Woes

As US drug shortages hit a five-year high and concerns mount about the safety of medicines, the Biden administration has quietly assembled a team to address chronic problems hurting America’s drug sup
Find out more
03 May 2023

Merck agrees to build bioprocessing production plant in South Korea

Merck’s Life Science business has entered into a non-binding memorandum of understanding (MOU) with the South Korean Ministry of Trade, Industry and Energy (MOTIE), and Daejeon City to establish a new
Find out more
28 Apr 2023

Big Pharma meets its match as EU refuses to budge

The European Union is set for a showdown with the pharma industry.Brussels held firm on a planned overhaul of its pharmaceutical rules on Wednesday, confirming a punishing new measure that will cut in
Find out more
20 Apr 2023

WHO launches mRNA vaccine hub in Cape Town

The World Health Organization (WHO) on Thursday officially launched its mRNA vaccine technology hub in Cape Town, a facility established during the COVID-19 pandemic to help poorer countries strugglin
Find out more
12 Apr 2023

Bioformulators Should Consider 3D Printing

Researchers behind a novel, non-injectable version of infliximab say 3D printing could help biopharmaceutical manufacturers overcome the formulation challenges associated with large molecule drugs.In
Find out more
04 Apr 2023

Bioprocesses at risk from proposed ‘forever chemicals’ regulations

Experts are calling on industry to respond to proposed rules restricting perfluoropolymers – commonly considered ‘forever chemicals’ – which are used in virtually all biomanufacturing processes.The Eu
Find out more
30 Mar 2023

EMA’s quality innovation group helps to propel regulatory path for novel technologies

BASEL, Switzerland – The European Medicines Agency’s (EMA) newly formed Quality Innovation Group (QIG) aims to clarify regulatory expectations for innovative manufacturing technologies to help bring t
Find out more
22 Mar 2023

Drug shortages are rising and pose a national security risk, new report warns

WASHINGTON — Children's medication, antibiotics and treatment for ADHD are among a number of drugs that have been in short supply in recent months — and the shortages of critical medications are only
Find out more

News